MEDIUM confidence: 100% data completeness, but the composite (54) sits in the indecisive 30–70 range — strong-buy and short calls require a more decisive composite. What does confidence mean?
Technical context for active traders — derived from price, the 50/200-day moving averages, the 52-week range, and recent volume. Not part of the QScore.
Fama-French 5-factor (2×3) + Momentum, monthly OLS with Newey-West errors. Bars show signed factor betas; faded bars/figures aren't statistically significant.
AI classification of policy/regulatory sensitivity from the company's sector, industry, and business description. Exposure/sensitivity only — not a political opinion, a prediction of government action, or investment advice. As of 2026-07-10.
Dated events from the market calendar; the “also watch” items are AI-generated observations from QScoring data. Informational only — not investment advice, and dates can change.
Net buyback (repurchases less issuance) ÷ market cap, plus trailing dividend yield.
| Metric (USD) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $36.5B— | $41.5B+13.8% | $34.7B-16.4% | $30.7B-11.5% | $32.5B+5.7% |
| EPS (dil.) | $23.16— | $28.79+24.3% | $18.00-37.5% | $8.46-53.0% | $7.52-11.1% |
| Free Cash Flow | $4.6B— | $8.1B+76.3% | $4.9B-39.7% | $806M-83.5% | -$188M-123.3% |
| Gross Margin | 30.2% | 30.1%-0.1pp | 22.5%-7.6pp | 13.3%-9.2pp | 11.9%-1.4pp |
| Operating Margin | 25.5% | 25.3%-0.2pp | 17.9%-7.4pp | 9.7%-8.3pp | 8.2%-1.5pp |
| Net Margin | 18.7% | 18.3%-0.4pp | 13.0%-5.3pp | 6.6%-6.4pp | 5.4%-1.2pp |
Absolute figures with year-over-year change. Margins show the level with the change in percentage points (pp). “n/m” = not meaningful (prior ≤ 0); ⚠ marks a large percentage off a small base — read the dollar figure.
Avg target $281 (last qtr, 10 analysts) → $286 (last mo, 5) (+1.9%).
Buy-rated share 76% → 82% over ~3 months (+6pp).
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jul 2026 | $4.46 | $4.84 | +8.5% |
| Apr 2026 | $2.82 | $3.23 | +14.5% |
| Jan 2026 | $1.91 | $1.73 | -9.4% |
| Oct 2025 | $2.18 | $2.63 | +20.6% |
| Jul 2025 | $2.55 | $2.60 | +2.0% |
| Apr 2025 | $0.69 | $0.77 | +12.1% |
| Jan 2025 | $0.94 | $1.22 | +29.8% |
| Oct 2024 | $1.50 | $1.49 | -0.7% |
Net insider -$33.6M over 180 days (0 open-market buys, 21 sells). Insider buying is the informative signal; routine selling is normal.
Short interest, days-to-cover, and institutional-ownership change require a data-plan upgrade (not yet available).
Forward-return IC, quintile spread & hit rate publish on /performance as the tracking panel accrues enough no-look-ahead history.
Working the DCF backward: holding the assumptions below, this is the free-cash-flow growth today's price implies over the next 10 years. It is a read on the price's embedded expectations — not a fair-value or target price.
The price implies FCF growth above the analyst consensus of 0.3%/yr (revenue basis).
Base free cash flow $1.8B (avg FY2023–FY2025; latest year -$188M) · equity value $61.9B · levered FCF discounted at the cost of equity. Reverse DCF is illustrative, not advice.
NUE's QScore of 54 indicates a neutral outlook, driven by strong momentum with a 92.1% return over the past year, but offset by weaker growth and profitability scores, including a decline in EPS growth of 11.1%. The stock trades at a moderate valuation with a P/E of 21.7, scoring 55 on value. Notably, the short-term score is 8 points higher than the long-term score, suggesting recent performance has been more favorable. Overall, NUE exhibits strong momentum but faces challenges in growth and profitability.